Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide as part of THE BALANCE GROUP. Our residence is in Mallorca, Spain. COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway. Clinical assessment determines the appropriate care plan and setting. In some cases, treatment may begin with an initial 1–3 days in a partner hospital for observation and stabilization before continuing at COGNIFUL. The pathway is planned around each person’s medical needs. This is not an independent ranking of identical luxury facilities. A provider’s general addiction service does not prove that it offers every sleep investigation or medication-withdrawal intervention.

Sleeping medication is a broad description. It may refer to a benzodiazepine, a Z-drug, another prescription medicine used for insomnia, or an over-the-counter product. These do not all have the same clinical profile. Start with the exact medicine, formulation, instructions and actual use rather than assume a single treatment applies to every product marketed or used for sleep. NHLBI describes several distinct medicine classes in its insomnia information. [2]

Physical dependence and addiction also differ. Dependence can arise with regular prescribed benzodiazepine use; a substance use disorder involves a broader harmful pattern, including impaired control. A person who becomes unwell after a medicine change should not automatically be described as addicted. Equally, a medicine originally prescribed for insomnia can later be used in a way that creates harm and loss of control. Assessment should distinguish these possibilities. [3]

Ask what has become difficult. Is the concern daytime sedation, fear of sleeping without medication, taking more than intended, obtaining additional supplies, poor sleep despite treatment, or a combination? Explain the original sleep problem and how life has changed since the prescription began. A useful formulation should describe both the night and the following day, including functioning, responsibilities and the person’s own priorities.

If the sleeping medicine is a benzodiazepine, abrupt stopping or rapid reduction can cause dangerous withdrawal, including seizures. Alcohol and opioids can add serious risks. Do not stop or replace medication independently to prepare for a program. The appropriate clinician should review the actual product and determine the support required for any change. Guidance for one medicine class should not be applied automatically to another. [4]

Tell the assessor about previous withdrawal, unusual reactions, falls, episodes of confusion and other medical conditions. Include alcohol and every sedating product, including those obtained without a prescription. This information helps clinicians decide whether ordinary outpatient review, a medically supported setting or another specialist service is necessary. It also helps prevent a sleep concern from being treated as a simple accommodation problem.

Severe confusion, a seizure, breathing difficulty, suspected overdose or immediate danger needs urgent local medical help. A private admissions team cannot replace emergency care, and an overseas journey should not delay assessment. Once immediate issues are managed, the person can consider the most suitable ongoing medication, sleep and psychological pathway. [4]

The comparison includes medical and addiction services because a sleeping-medication concern may require more than residential psychotherapy. It does not claim that all listed providers operate specialist sleep laboratories or offer CBT-I. Ask each about the exact product, the medical plan and the sleep expertise available. A provider should distinguish services it delivers directly from those it arranges through another professional.

For an overseas option, ask where any necessary stabilization would happen and whether the next provider has accepted the transition. A short detox package and a longer residential stay may serve different purposes. Neither should be treated as evidence that the underlying insomnia or harmful medication pattern has been fully addressed. The useful comparison follows the entire care sequence.

Describe the pattern over a typical week

Explain when sleep is difficult, how nights vary and what happens the following day. Include work schedules, travel, opportunities for sleep and how medication is used in relation to those patterns. A short account of several ordinary days can be more informative than describing only the worst night. The clinician may ask for further structured information, but the goal is understanding rather than achieving a perfect record.

Ask whether another medical or sleep condition needs assessment. A residential provider should not assume that every sleep difficulty is psychological or caused by addiction. The question is which professional will investigate relevant symptoms and how those findings influence treatment. If specialist sleep medicine is needed, establish the referral rather than infer that it is included in a broad wellness program.

Explore the meaning of the medication

A sleeping tablet may have become associated with safety, control or the ability to function the next day. Someone may fear that discussing dependence will mean being left without help. Treatment should take that concern seriously while assessing the actual benefits and harms. The conversation should not become a demand to prove motivation by stopping medication before a medical plan exists.

If use has become difficult to control, ask how therapy addresses the surrounding pattern. This may include repeated extra doses, obtaining pills from several sources, using medication outside bedtime or avoiding honest discussion with clinicians. The work should connect the behavior with practical goals and support, rather than reduce recovery to a single measure of how many tablets are prescribed.

Assess daytime functioning

The desired outcome is not merely a reported number of hours asleep. Discuss concentration, mood, participation in ordinary activities and the ability to meet essential responsibilities. A person may judge a night as poor while still functioning reasonably, or feel they slept while remaining impaired during the day. These experiences need clinical interpretation and should inform realistic goals for treatment.

NHLBI identifies cognitive behavioral therapy for insomnia as a usual first treatment for long-term insomnia. It is a structured approach addressing thoughts, behavior and the sleep pattern, rather than a general promise to relax. When comparing programs, ask who delivers appropriate insomnia care, what assessment precedes it and how it is coordinated with medication review. [2]

Do not assume that a list of yoga, massage or mindfulness activities establishes CBT-I or specialist sleep treatment. Such activities may be part of a person’s broader routine, but their presence does not answer the clinical question. Request a direct explanation of the proposed sleep work and whether it is included, referred elsewhere or not available. The answer should be specific to the assessed need.

Ask how treatment will remain usable after discharge. If the person’s work involves irregular hours or frequent travel, a plan built only around the residence’s schedule may be difficult to maintain. Discuss the actual constraints with the appropriate professional. The aim is not to reproduce the residence indefinitely, but to develop a workable approach within the person’s life and ongoing medical care.

For dependence without addiction, an outpatient clinician-led review may be sufficient and may offer useful continuity. For a harmful pattern of use, addiction treatment may need to address coping, access to medication and associated mental health concerns. If withdrawal or other risks require a higher level of care, a medical service should come first. The same sleeping-pill label can therefore lead to different recommendations. [1] [3]

A residential stay needs a defined purpose. Ask what will be possible there that is difficult in the existing setting: sustained therapeutic work, protection from disruptive demands, a structured routine or careful transition planning. These aims should be linked to the person’s history. A private suite alone is not a clinical reason for admission, and a high price does not establish superior sleep outcomes.

The proposal should also explain its limits. Which medical symptoms require external assessment? Who is available between appointments? What happens if the person needs a different level of care? An honest answer about those limits is more useful than a broad claim of comprehensive support. The clinical plan and the living arrangements should be evaluated separately and then connected where appropriate.

Before travel, confirm the exact medicines, responsible prescriber and dispensing arrangements. Check the actual route’s requirements with the relevant authorities and clinicians. Do not assume a familiar brand or formulation will be available abroad or that a prescription can be used unchanged in every country. The goal is continuity under professional oversight, not self-directed substitution.

Ask how records will be transferred and which language the clinical team will use. Sleep experiences can be difficult to describe, so the person should be able to discuss them accurately. Family members can help with logistics without becoming the only interpreters or holding all communication with the program. Agree what information can be shared and with whom.

Time-zone changes can also affect the transition. Discuss arrival and return arrangements with the relevant clinician so that travel is considered within the treatment plan. This is particularly important when the person’s everyday schedule differs sharply from the residence. Avoid treating the journey as a reason to independently adjust sedating medication or combine products.

COGNIFUL considers sleeping-medication concerns through its prescription-medication suitability process in Mallorca. That process should establish the actual problem, current stability and need for medical or specialist care. It does not automatically label every insomnia prescription as addiction. Medical withdrawal management or another service may be required first, and onsite detoxification should not be assumed from the residential description. [1] [9]

COGNIFUL Premier and Premier Plus use a residence for a maximum of four clients at any time, each with a private suite. Clinical and bodywork sessions are individual. The residence, chef, personal manager, other holistic sessions, excursions and activities are shared. This format may be considered by someone who wants personal clinical work and space to rest within a small shared setting. It does not establish a dedicated team, specialist sleep equipment or a particular monitoring capability. [8]

Ask how the proposed residential work would connect with the sleep and medication concerns identified in assessment. What goals would be addressed? Which professionals would contribute? If a specific insomnia intervention or medical review is needed, is it available directly or through an agreed external service? The individual proposal should answer those questions rather than let the person infer specialist capability from general treatment language. [9]

COGNIFUL Premier and Premier Plus both include assessment, a personal treatment plan and continuing-care planning. Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Follow-up for the base program is agreed individually. Typical residential stays are four to twelve weeks, reviewed for the person. This is not a guarantee about the duration of insomnia or medication withdrawal. [8] View program fees

The program choice should be related to concrete needs, such as additional work on family expectations or a complicated return to ordinary routines. Ask exactly what the additional services involve. Obtain a written proposal stating duration, total fees, inclusions and possible extra costs. COGNIFUL is generally self-pay, does not bill insurers directly and cannot guarantee reimbursement. External sleep or medical services should be clarified separately.

Continuing care should connect the residential phase with the clinician who will review medication and sleep after the stay. Confirm appointments, accepted responsibilities and the practical format of follow-up. COGNIFUL’s continuing-care planning supports preparation for home, but it does not establish unrestricted cross-border prescribing or universal remote access to every service. [10]

Separate what you know from what you suspect. You may know that a tablet was taken, that the following morning felt difficult and that work performance changed. You may not know whether the cause was the medicine, fragmented sleep, anxiety or another condition. Presenting the sequence clearly allows the clinician to investigate without turning a plausible explanation into a certainty. Bring earlier reports if a sleep disorder has already been assessed.

It can also help to describe what the person hopes treatment will make possible: participating in family life, feeling less afraid of bedtime, managing work without repeated extra medication, or speaking honestly with the prescriber. These aims are more useful than a demand for perfect sleep every night. A good plan can connect them with appropriate clinical goals while acknowledging that progress may be uneven and that ongoing care may remain necessary.

• What exact medication-related problem has been identified, and is addiction actually present?
• Who assesses the insomnia and any other possible sleep or medical condition?
• Which service manages withdrawal risk or prescribing changes?
• What evidence-based sleep treatment is available and who provides it?
• How will the plan work with the person’s real schedule after discharge?

Ask each provider to answer in relation to the same history. A person should be able to compare the clinical plan, external requirements, living arrangements and costs without guessing what is included. If a proposal is mainly a promise of peaceful surroundings, the medication and sleep-treatment questions still need answers.

Are all sleeping medicines addictive?

No single statement fits every product used for sleep. The exact medicine and pattern of use matter, and physical dependence is not the same as addiction. A clinician should review the product, benefits, harms and appropriate next step. [2] [3]

Does a good night’s sleep in a residence prove the problem is resolved?

No. Treatment should consider the broader pattern and daytime functioning, as well as what happens after returning home. A different environment can change routines without resolving the medication or sleep-related needs that require ongoing care.

Does COGNIFUL provide a dedicated sleep-medicine or detox service?

Those capabilities should not be assumed. Sleeping-medication concerns are considered through prescription-medication assessment, and any required specialist sleep or medical withdrawal service must be confirmed separately. [1] [9]

Should I stop sleeping tablets before treatment?

Do not make independent changes to prepare for admission. The exact medicine determines the risks, and abrupt benzodiazepine withdrawal can be dangerous. Ask the responsible clinician to guide the plan. [4]

Contact COGNIFUL admissions to explain the actual sleeping medicine, what has become difficult and which clinicians are involved. The team can outline suitability review and the Mallorca residential format. The next step should clarify both the medical pathway and the role of residential work, with a practical plan for continuing care. [8]

1. Prescription medication concerns and residential treatment — COGNIFUL.
2. Insomnia treatment — National Heart, Lung, and Blood Institute.
3. Joint Clinical Practice Guideline on Benzodiazepine Tapering — American Society of Addiction Medicine and partner societies.
4. Benzodiazepine safety communication — US Food and Drug Administration.
5. Psychiatry and Clinical Psychology Department — Clínica Universidad de Navarra.
6. Priory Hospital Roehampton — Priory.
7. Addiction and mental health services in Center City — Hazelden Betty Ford Foundation.
8. COGNIFUL programs, fees, admissions and suitability — COGNIFUL.
9. Clinical scope, suitability and care coordination — COGNIFUL.
10. Reintegration and continuing care — COGNIFUL.

Primary clinical and provider pages accessed October 18, 2026. Individual services, admission and fees should be confirmed directly.